tackle
The National Federation of Pr05tate Cancer Support Groups
Report of Directors and Financial Statements
for period ending 31st December 2023
prostate cancer
THE NATIONAL FEDERATION OF PROSTATE
CANCER SUPPORT GROUPS
REPORT OF DIRECTORS AND FINANCIAL
STATEMENTS
FOR THE PERIOD ENDING
31ST DECEMBER 2023
Registered Charlty No (England & Wales): 1163152
A company Ilrnlted by guarantee. Registered ID England & Wales: 9672970
Reglrtered Offlce: 124, City Road, London. ECIV 2NX

tackle
The Natw)nal Federation of Pr05tate Cancer Support Groups
Report of D1￿CtorS and Financial statements
for period ending 31st December 2023
prostate cancer
Board of Directors
Llst of all Dlrectors seNlng in 2023:
Stephen Allen
Appointed February 2022
Aidan Adkins, Co-chair
Appointed February 2022
Frank Chine8wundoh MBE
Appointed February 2022
Anthony Colller
Appointed March 2023
Peter Corbishley
Appointed March 2023
Angela Jones, Flnance Director
Appointed December 2022
Kyriak05 Ma5tris
Appointed March 2023
Roshani Perera . Co-chair
Appointed March 2020
Alphonso Archer
Resigned March 2023
John Coleman
Resigned March 2023
Simon Faulkner
Appointed March 2023 Resigned December 2023
Charity Registration Number 1163152
Company Registration Number 9672970
Registered Office
124 City Road
London ECIV 2NX
Independent Examiners
TGFP Fulford House Newbold Terrace
Leamington Spa
CV32 4EA
Bankers
CAF Bank
Kings Hill
West Malling
ME19 4TA Solicitors

tackle
The Natlonal Federation of Prostate Cancer Support Groups
Report of Directors and Financial statements
for period ending 31st December 2023
prostate cancer
The Tru5tee5 are pleased to present their annual directors, report together with the financial
statements of the charity for the year ended 31 December 2023 which are also prepared to meet the
requirements for a directors, report and accounts for Companies kt purposes.
The financial statements follow the Charities Art 2011. the Companies Act 2CM)6, the charlty's
Memorandum and Articles of Association, and the Statement of Recommended Practice: Accounting
and Reporting by Charities applicable to charities preparing their accounts by the Financial Reporting
Standard applicable in the UK and Ireland IFRS 1021 {effective l January 20151.
sTRU￿URE. GOVERNANCE AND MANAGEMENT
Governlng Document
The National Federation of Prostate Cancer Support Groups I0￿rating under the name.. Tackle
Prostate Cancerl is a charitable company limited by guarantee, incorporated on 6 July 2015, and
registered as a charity on 14 August 2015. On l January 2016. The National Federation of Pr05tate
Cancer Support Groups acquired the whole of the assets and liabilities of the unincorporated
association Prostate Cancer Support Federation IPCSFI. PCSF had been formed in September 2CI)7
and was dissolved in February 2016. The company was set up under a Memorandum and Articles of
Association (Articles) which set up the objects, powers. and governance of the company. These
Articles were revised and adopted by special resolutlon on 6 February 2023.
Recruitrnent. induction, and training of Dirertors {Trusteesl
The Board consists of not less than three nor more than ten Dlrectors made up as follows..
Up to seven Directors being members of member organisations and elected by the member5
at the Annual General Meeting
Up to three Directors appointed by the Board who have a speclfic expert5se e.8., finance, HR
or marketing= and
The Directors shall appoint one of their number as Chair and may determine the length of
term to se￿e in that office. The Directors may also appoint one of their number a5 vice-
hair.
Directors are a150 Trustees of the charity and govewn the activities of the Charity as a Board. Upon
appointment to the Board, to help ease their understanding of the current 155ues concerning the
organisation, each new Director is provided with a copy of the Charity Commission publication
entitled "The Essential Trustee: What you need to know" which gives guidance on what is expetted
of them. New Directors are a150 provided with briefing5 from the Chair on the structure, strate8y and
operation5 of the charity. The Board meets four times a year and devolves resF)onsibility for
overseeing the day-to-day running of the organisation to the executive team currently led by Sarah
Gray and overseen by the Chair and Vice-chair. Sub-committees with Trustee representotion is in
place to govern specific activities such as fundraising, marketing, appointments and renumeration.

tackle
The National Federation of Prostate Cancer Support Groups
Report of Directors and Financial statements
for period ending 31st December 2023
prostate cancer
The purpose of the charlty
The charity 15 a federation, whose member organisations I"members°l are patient-led prostate
cancer sUPPOrt groups. The purpose of the charity is to Co-ordinate, focus and strengthen the efforts
of prostate cancer patients in general. and its member organisations specifically. in their cause to
alleviate the plight of those affected by prostate cancer.
Oblertlves and artlvltles for the public benefit
As set out in its governing document, the objects of the charity are to relieve the Sickness, physical
and mental distress of persons affected by prostate cancer in the UK, but not exclusively by:
aS5iSting and strengthening the activities in support of people affected by prostate cancer.
including encouraging and supporting the formation of new local prostate 5UPPOrt
organisations throughout the UK
encouraging the improvement of health Services available to prostate cancer patients; and
acting as a focus for and expresslng the views of patient-led support groups concerning
raising awareness of prostate can￿r
b. Improvlng the health Se￿iCe5 available to prostste cancer patients: and
c. priorities for research Into the diagnosls and treatment of prostate cancer.
Our vision 15 to be the 'go to, charity for peer svpport and our mission is To enable the growth of
peer support groups acr055 the country, ensuring the needs of people living Wlth and impacte
by prostate cancer are met. and their voices are heard.
Our strategic imperatives as set out in our 3-year plan12023-20261 are to:
Grow and strengthen ¢)ur ￿lationShipS and reputatlon amongst peer support groups
Recognise and amplify the importance of the user voice acros5 the health and social ￿re
System
Demonstrate our Impact and value to the prostate cancer communlty and general publk
Secure flnanclal sustslnabS11ty through an effective fundraisin8 strategy
Ensure we have robust organlsatlonal governance to deliver our strategy and mandatory
requirements
Achlevements In 2023
Over the last three years, we have fom)allsed our federation, whllst working with and11slenlng to
our members to develop a package of support. This enabled existing peer support groups to learn
from one another and offer a space for people affected by prostate cancer to receive information
and emotional support following their diagnosis. It has also enabled us to support the establishment
of new groups in areas where there has historically been a gap in provision. The Tackle member
organisations have grown from 80 to over 120 group5 resulting in regular indired contact with
around lo.￿0 people per year through our Support Group Leaders.
Our offer to groups now includes monthly briefings of adivity, useful infomi3tion, and best practice
for 281 group leaders and those in an organising role- hosting and facilitating monthly group leaders
nettvork meetings- regular updates from representatives from other organisations, such as

tackle
The Nalional Federation of Prostate Cancer Support Groups
Report of Directors and Financial statements
for period ending 31st December 2023
prostate cancer
Macmillan or Prostate Cancer UK IPCUKI- hosting and facilitating regional networkin8 events for
peer support group leaders and organisers, plus an annual conference in Spring each year.
In 2023. we trained 15 peer coaches, made 40 group vlslts (ln person and online), responded to 800+
enquiry emails and phone calls from groups, hosted 12 support group leaders, meetings With an
average attendance of 28 people per month, and offered over £3,tXJO in support grants for local
groups. We also supported three Equality Diversity and Inclusion workshops. with a total of 63
people attending through our work with the Metro charity-
Entering a formal partnership with Prostate Cancer UK {PCUKI in 2023 recognised us as the 'go to
charity, for peer support. No longer a shared responsibility. Tackle took on sole ownership for
supporting local peers support groups across the country regardless of whether a group was part of
our membership or not. We have established strong links with PCUK and our relationship enables
two-way conversations to support local groups with the necessary resources you require whilst
amplifying your voice through their campaigns and research. An exemplar of our collaborative
campaigning has been the Boys need Bins campaign which reached out to 95% of MPS urging them
to SUPPOrt the campaign, attendance at our Westminster event with representatlves from our
membership, significant media coverage and actual implementation acr055 several regions in the
country starting wlth Wlnchester Councll and Hampshire County Council.
We have extended and nurtured our relationships with Support Groups and Organisations for Black
Men, including Black Cancer Care, Errol McKellar Foundation and Cancer Don't let it Win. We have
also worked with LGBTQ+ groups and the Metro charity. Our intention is to collaborate with these
groups further to extend our reach and support to those underserved populations as we continue in
our endeavours. Our work to tackle more inclusive representation of the prostate cancer community
Is a corner stone of our'LeVs Talk About It, campaign, which aims to share the lived experiences and
the benefits of peer support to a wider audience.

tackle
The National Federation of Pr05tate Cancer Support Groups
Report of Directors and Financial statements
for period ending 31st December 2023
prostate cancer
FINANCIAL REVIEW
Financial Performance
Our income thi5 year at £123,366 was an increase of 3% on 2022. Our expenditure of £154.336 was
up by 25% overall. with charitable expenditure increased by 29%. We finished the year with a deficit
of E30.969.
As recognised by the Board in their risk assessment. fundrai5in8 continue5 to be a serious challenge
for the Charity. We are extremely grateful to all our member5 and sUPPQrters for their generosity in
donating funds to cover the work that we do to support prostate cancer patients and their families.
In line with ABPI guidelines. we continued to benefit from financial support from pharmaceutical
companies, Some of whom we work closely with as patient advocates.
Reserves Policv
In line with the guidance issued by the Charity Commission. the Trustees have considered the future
needs of the charity and believe that unrestricted general funds, that is funds which are neither
restricted nor desi8nated, should be at least three months, forward operating expenditure. Such
fijnds are needed to safeguard the tharity's activity against an unexpected shortfall in fundraising
income, emergency, or unforeseen expenditure and to ensure its financial stability over the longer
term.
Statement of Trustees, Responslbllltles
The Trustees (who are also the Directors of the charitable company for the purposes of tompany
lawl handle preparing the Annual Report and financial Statements following applicable laws and
United Kingdom Generally Accepted Accountin8 Practice.
Company law requires the charity trustees to prepare financial statements for each year which give a
true and fair view of the situation of the charitable company and of the incoming resources and
application of resources including the income and expenditure of the charitable company for that
period. In preparing those financial statements, the trustee5 must:
select suitable accounting policies and then apply them consistently.
ob5eNe the fflethods and principles in the Charity SORP 2015 IFRS 1021.
make judgements and estirnates that are reasonable and prudent.
state whether applicable accounting standards have been followed- and
prepare the financial statements on the going concern basis unless it inappropriate to
presume that the charitable company will continue in business.
The trustees handle keeplng proper actounting records which show with reasonable accuracy at any
time the financial positlon of the charitable company and to enable them to ensure that the financial
statements follow the Companies Act 21X)6. They are also responsible for safeguarding the assets of
the charitable company and hence for taking reasonable steps forthe prevention and detertion of
fraud and other irregularities.
The trustees handle the maintenance and integrity of the corporate and financial Information
included on the charitable compaT)y website. Legislation in the United Kingdom governing the

tackle
The National Federation of Prostate Cancer Support Groups
Report of Directors and Financial statements
for period ending 31st December 2023
prostate cancer
preparation and di55emination of financial statements may differ from legislation in other
jurisdictions.
This report was approved by the Board of Trustees and signed on its behalf by:
5 July 2024
R05hani Perera

The National Federation of Prostate Cancer Support Groups
(operating as Tackle Prostate Cancer)
Indèpendent Examlner's Report to the Trustees of
The Natlonal Federation of Prostate Cancer Support Groups
I report to the charity trustees on my examination of the accounts of the company for the year
ended 31 December 2023, which are set out on pages 12 to 21.
Responsibilities and basls of rèport
As the charity trustees of the company (and also its directors for the purposes of company
law) you are responsible for the preparation of the accounts in accordance with the
requirements of the Companies Act 2006 ('the 2006 Act.).
Having satisfied myself that the accounis of the company are nol required to be audited
under Part 16 of the 2006 Act and are eligible for independent examination, I report in
respect of my examination of your company's accounts as carried out under section 145 of
the Charities Act 2011 ('the 2011 Act,). In carrying out my examination I have followed the
Directions given by the Charity Commission under section 14515){b) of the 2011 Act.
Basis of independent examiner's report
My examination was carried out in accordance with the general Directions given by the Charity
Commission. An examination includes a review of the acwunting rewrds kept by the charity and a
comparison of the accounts presented with those records. It also includes consideration of any
unusual items or disclosures in the aocounts, and seeking explanations from you as trustees
¢onceming any such matters. The procedures undertaken do not provide all the evidence that
would be reqUI￿d in an audit and consequently no opinion is given as to whether the accounts
present a 'true and fair vi8vl and the report is limited to thos8 matters set out in the statement
below.
Independènt èxaminer's statement
I confim that l am qualified to undertake the examination because l am a member of the Institut6
of Chartered Accountants in England and Wales. I have completed my examination. I confimi that
no matters have come to my attention in connection with the examination giving me cause to
believe that in any material respect=
accounting records wera not kept in respect of the company as required by section 386 of
the 2006 Act., or
2. the accounts do not accord with those records. or
3. the accounls do not comply with the accounting requirements of section 396 of the 2006
Act other than any requirement that the accounts give a 'true and fair view. which is not
matter considered as part of an independent examination: or
4. the accounts have not been prepared in accordance with the methods and principles of the
Statement of Recommended Practice for accounting and reporting by charities (applicable
to charitles preparing their a¢¢ounts in accordan￿ with the Financial Reporting Standard
applicable in the UK and Republic of Ireland (FRS 102)-

The National Federatlon of Prostate Cancer Support Groups
(operating as Tacklè Prostate Cancer
Independent Examiner's Report to the Trustees of
The Natlonal Foderatlon of Prostste Cancer Support Groups - continued
I have no wncerns and have come across no other matters in Gonne¢tion with the examination to
which attention s
uld be drawn in this report in order to enable a prop8r understanding of the
accoun
tobe
Ched.
BE
TGFP
Chartered Accountants & Statutory Auditors
Fulford House
Newbold Terrace
Leamington Spa
CV32 4EA
IN R REYNOLDS Bsc (Hons) FCA.
Date:

Tho National Federation of Prostate Cancer Support Groups
{operating as Tackle Pro$L￿O Cancer)
Statement of Financial Activltles
for the year ended 31 December 2023
INCOME AND EXPENDITURE
Unrestricted
Funds
Restricted
Funds
Totsl
2023
Total
2022
Note
Incoming Resource5
Voluntsry income
Invesknenl income
74,067
667
48.633
122.700
667
119.873
378
Total Income
74.733
48,633
123.366
120.251
Expertditure on:
Raising funds
Charitable activlties
11,867
54.701
11,867
142.469
13,703
110,097
87,768
Totsl Ex￿ndItUr0
66.568
87.768
154,336
123,800
Not Incom•llExpendlture)
8,166
139.135)
{30.9691
(3.5491
Net Movement In Funds for the Year
8,186
{39.135)
(30.969)
13.5491
Reconc611atlon of Funds
Total funds blf at 1 Jan 2023
106,867
88.193
195.080
198,609
Total fvnds ctt al 31 DOG 2023
10
11 5,035
195,060
The statement of financial activitiès Includes all gain$ and losses reccgnised in Ihe year. All incc4ne and
expendiiure derives from conlinulng activities.
pa￿.. 10

The Natlonal Federatlon of Prostate Cancer Support Groups
(operating as Tackle Prostate Cancer)
Statement of Financial Activities
for the year ended 31 December 2023
2023
2022
Fixèd As8•ts
Current Assets
Debtors
Cash at bank and in ha￿1
11,865
157,846
169.711
1.873
200,939
2112,812
Creditors: Amounts falling due
within one year
5,621
7.752
Net CuTrenl Assets
164,091
1g5,060
Net Assets
Represented by:
Restricted Funds
10
49,058
88.193
General Unrestricted Funds
Designated Funds
10
10
90,035
25.000
115.035
81,867
25,OCIJ
11￿,867
Total Funds
The Th)tes on pages 15 to 21 fomi part of these financial statements.
The charitable company 15 entitled to exemption under Section 477 of the Companies Act 2LK6 for
the year ended 31 December 2023.
The directors have not requlred the company to obtain an audit of its financial ststemonts for the
year ended 31 D￿ember 2023 in a¢¢ordan¢e with Section 476 of Ihe Companies Act 2(K)6.
The directors acknowledge their resrx)nsibilities for..
(a) ensuring that the charitable company keeps accounting records that comply with
Sections 386 and 387 of the Companies Act 2006 and
(b) preparing financial statements wlwch give a trne and falr view of the state of affairs of the
charitable company as at the erKI of each financial year of tLs surplu5 or deficit for
each financial year in accordance with the reqLJirements of Sections 394 and 395 and
which Ot￿lSe comply wrth the requirements of the Companies Act 2006 relating to the
financial statements. so far as applicable to the charitable company.
These financial statements have been prepared in accordance with the speci81 provi8ions of
Part 15 of the Companies Act 2006 r&lating to charitable small companies.
The financial statements were approved by the Board on
and signed on ils behalf by:
Chamintha Roshani Perera
Ch8imian
Angela Jonés
Director
Page.. 11

The National Federation of Prostate Cancer Support Groups
(operating as Tackle Prostate Cancer)
Statement of Financial Activities
for the year ended 31 December 2023
Note
2023
2022
Cash Flows from Operatlng Actlvltles
(43,092)
45.180
Increasel(De¢rease) in Cash and
Cash Equivalents in the Year
(43,093)
78.870
Cash and Cash Equlvalants at the
Beglnnlng of the Year
200,939
122.069
Cash and Cash Equivalents at the
End of the Year
157,846
2￿,939
NOTES TO CASH FLOW STATEMENT
Note A
Net Incomel{Expenditure) for th8 Yèar
Adjustment for.
Decreasel{Increase) in Debtors
Increasel{Decrease) in Creditors
(30,969)
43,978
{9,992)
2,131
{86)
1.288
Net Cash fromlused in OperatI￿j Activrties
43,092
45.180
Page.. 12

The National Federation of Prostate Cancer Support Groups
(operating as Tackle Prostate Cancer)
Statement of Financial Activities
for the year ended 31 December 2023
Accountlng Pollcles
Th8 following principal accounting policies have been consistently applied in preparing thes8
financial statements.
Basls of preparalion
The financial statemènts have been prepared in accordance wlth Accounting and Reporting by
Charities.. Ststement of Recommended Practice applicablè lo charities preparing their accounts in
accordance with the Financial Reporting Standard applicable in the UK and Republic of Ir8iand
(FRS 102) (effecllve 1 January 2015)- Charities SORP {FRS 102), and the Companies Act 2006.
The National Federation of Prostate Can￿r SupF)Ort Groups meets the definition of a public benefrt
entity under FRS 102. Assets and liabilities are initially recognised at historical cost or transaction
value unless otherwise slated in the relevant accounting polioy note{s).
The flnanclal statements are prepared on a going eoncem basls under the historical cost
convention modifièd to indude certain items at cost value.
The financial statements are prepared in stsding, which is the functional currency of the charity and
rounded to the nearest £.
Income
Voluntsry inoyne and donations aro included in the financial period to which they relate where it is
certain that monles bMII not be repayable. Voluntary income is reeognised logether with the
associated reclaim of tsx where appropriate.
During the year there were donated services totalling £2,000 {2022: £2,000) based upon valuations
at a fair market value.
Resources expended
All expenditure is aw)unted for on an accruals basls and Is dlrectly classrfied under the
expenditure category to which it r8late5. Support costs have been allocated to the charltab18
activity to which they relate.
Expenditure on raising funds comprises those costs relating to activities where the primary aim is to
raise funds, along with an apportlonment of support costs.
Expenditure incurred in connection with the specific objects of the Charity is included under the
heading Charitable Activities and includes an apportionment of support costs.
d. Flxed assets
The Charity does not have any fixed assets. The Trustees rx)nsider the provision of all office
equlpmant to be part of the running costs of the organisalion and il is written off in the year of
purchase.
Ta￿tiOn
No charge to taxation arises on the result for the year because the company is able to take
advantage of the tsx exemplions available to charlties.
Page: 13

The National Federation of Prostate Cancer Support Groups
(operating as Tackle Prostate Cancer)
Statement of Financial Activities
for the year ended 31 December 2023
1 Accounting Pollcl•s (continued)
Operating lèasès
Rentals payable under operating leases are charg8d against income on a straight line basis over
the lease temi.
g. Flnancial Instrumonts
Basic financial assets, which inolude cash and bank balances. aré initialty measured at transaction
price in¢luding transaction ¢osts and are subsequently carried at amortised cost using the effective
interest method unless the arrangemenl constitutes a financing transaGtion, where the transaction
is measured at the present value of the future receipts discounted at a market rate of interest.
Financial assets classified as receivable within one year are rKJt amortised.
h. Funds
General fiinds - these ar8 unr8Stricted funds which can b8 used for the charitable obje¢ts at the
discretion of the Trustees and which have nol been designated for other purposes.
Rèstrictèd funds - these are funds that can only be used for parti¢ular restri¢ted purposes wilhin
the objects of the charity- R6Striclions aris8 when specified by the donor or when funds are raised
for particular restricted purposes. Th8 aim and us8 of each r8Strict8d fund is s8t out in the notes to
the financial statements.
Designated funds - these are unre$tri¢ted funds which have been set aside by the Trustees for
specific purposes. The aim and usè of each designated fund is set out in the notes to the financial
statements.
Interest recelvabla
Interest on funds held on d8POSIt is included when receivable., this is nornally upon receipt or upon
notification of the interest paid by the Bank or Building Society.
Pension costs
The Charity operates a defined Contrib￿lon stskeholder pension scheme. The amount charged to
the statement of finanGial activities in respect of pension costs is the Charitls contributions payable
in the year. The assets of the scheme are held separately from the Charity. There was no
outstanding liability owed to the scheme at the end of the current or prior years.
k. Employeo Bonefits
The cost of short-terrn 8mployee benefits are r8cognised as a liability and an expense. The cost of
any material unused holiday entitlement is r8cogniséd in the period in which the employee s
services are received.
Pag&: 14

The National Federation of Prostate Cancer Support Groups
(operating as Tackle Prostate Cancer)
Statement of Financial Activities
for the year ended 31 December 2023
2 Voluntary incom•
Unrestricted
2023
Restricted
2023
Total
2023
Total
2022
Donatlons recelved from..
Members
Individuals and Community
Trusts and Foundations
Cornpanies
10.717
24.950
38,400
10,717
73,583
38,400
2,459
95,867
21,547
48,633
74,067
119,873
Of whlch In 2022:
Unrestricted
Restricted
39,477
80,396
119,873
For a breakdown of prior year comparatives. see note 12
3 Fundraising Activities
Unrestricted
2023
Restricted
2023
Total
2023
Total
2022
Fundraising Costs
Support Costs
Govemance Costs
11.867
11.867
13,350
353
Of which in 2022:
Unrestricted
Restricted
13,703
For a breakdown of prior year comparatives, see note 12
4 Charitable Activit108
Note
Unrestricted
2023
R8Stricted
2023
Total
2023
Total
2022
Campaigning & Awaren6SS
Groups Support
Staff Cosls
Support Costs
Govemance Costs
13,236
3,153
6.003
17,126
15,183
6,702
20,575
47,654
12,245
592
19.938
23,728
53,657
29.371
15.775
12,559
38,230
44,598
9.678
5,032
110097
Of which in 2022:
Unrestricted
Restricted
24,661
85,436
110097
For a breakdown of prior year Comparatives. see note 12
Page= 15

The National Federation of Prostate Cancer Support Groups
(operating as Tackle Prostate Cancer)
Statement of Financial Activities
for the year ended 31 December 2023
S Support and Governance Costs
Support Govemanco
Costs
Costs
Total
2023
Total
2022
Other Costs
Bank Charges
Trustee Meetings and Expenses
Audit
Legal & Professional Fees
26.201
72
3,097
14,652
40,853
72
3,488
9,950
81
369
390
733
733
4,663
29,371
Basis of
Allocation
O.OO/o
100.0%
AlloGated to fundraising costs
Allocated to charitable activities
29,371
15.775
45,146
100.0%
6 Staff Cost8
2023
2022
Salaries and wages
Social security costs
Pension contributions
Recruitment
Training
52,481
44,573
310
429
438
24
Total employee costs
53,657
44.597
No employee eamed in excess of £60.000 p.a.
The key management personnel of the Charity are the Trustees who do not receive
remuneration but during the year the charity paid aggregate expenses lolalling £3,488
(2022: £8161 relating to 9 {2022'. 3) trustees in respecl of travel, a¢¢omm¢)dation and
The ch8rity indudes Trustees, Liability Insurance in its combined insurance policy.
The average number of employ88s (h8adcount based on number of staff employed)
during the year was as follows..
2023
2022
Engagement
7 Debtors
2023
2022
Other debtors
PrÈpayments
11,250
615
1,738
135
1,873
Page.. 16

The National Federation of Prostate Cancer Support Groups
(operating as Tackle Prostste Cancer)
Statement of Financial Activities
for the year ended 31 December 2023
8 Creditors: amounts falling due within one year
2023
2022
Trade creditors
Taxation and Social Securty
Accruals
Other Creditors
1.828
2.632
1,028
133
4.626
1,965
1.028
133
9 Analysis of Net Assets between Funds
Unrestricted Restricted
Funds
Funds
Total
Funds
Total assets
Current liabilities
Net Assets at 31 Dec 2023
120,655
(5,621)
115,035
49,056 169,712
(5,621)
49,056 164,091
For a breakdown of prior year comparatives, see note 12
10 Movements in Funds
1Jan
Incomlng
Outgoing
Fund
2023 Resources Resources Transfers
31 Dec
2023
Unrestricted Funds:
General
81.867
Designated - Development Fund 25,000
74.733
(66,567)
90.035
25,000
Total Unrestricted Funds
106,867
74.733
(66,567)
115.035
Restricted Funds:
Tackle Man Van
National Lottery Community
Fund
Tackling Proslat8 Cancer- peer to
peer support for men wth prostste
cancer
2,500
2,500
55,936
29,757
41.633
(82,973)
4.796
14.596
31.961
other restricted funds
Total Restricted Funds
88,193
48.633
87,769)
49,056
Totsl Funds
195 060
123366
154336
164 091
For a breakdown of prior year comparatives, see note 12
Page: 17

The National Federation of Prostate Cancer Support Groups
(operating as Tackle Prostate Cancer)
Statement of Financial Activities
for the year ended 31 December 2023
12 Comparative Note Only
Note 2 - Voluntary Income
2022
Total
Unrestricted
Restricted
Donations received from."
Members
Individuals and Communty
Trusts and Foundations
Companies
2.459
17,921
19,097
2A59
95,867
21,547
77.946
2.450
80.396
119873
Note 3 - Fundraising Activities
2022
Total
Unrestricted
RestriGted
Fundraising Costs
Supporl Costs
Governance Costs
13.350
353
13.350
353
13.703
13.703
Note 4 - Charltable Activities
2022
Total
Unrestricted
Restricted
Campaigning & Awareness
Groups Support
Staff Costs
Support Costs
Govemance Costs
2.091
8,122
25
9,391
5.032
10.468
30,108
44,573
287
12,559
38,230
44,598
9,678
5,032
24.661
85,436
110.097
Note 9 - Analysis of Net Assots between Funds
Unrestricted
Funds
2022
Totsl
Funds
Restricted
Funds
Total assets
Current liabilities
Net Assets at 31 Dec 2022
110.816
(7.752)
103 064
88.192
199.008
(7,752)
191256
88,192
Page.. 18

The National Federation of Prostate Cancer Support Groups
(operating as Tackle Prostate Cancer)
Statement of Financial Activities
for the year ended 31 December 2023
12 Comparatlvo Noto Only (continued)
Note 10- Movements In Funds
1Jan
Incoming Outgoing
Fund
2022 Resources Resources Transfers
31 Dec
2022
Unrestrictsd Funds:
General
80.377
Designated - Development Fund 25.000
39.855
(38.365)
81,867
25,000
Total Unrestricted Funds
105.377
39,855
(38.365)
106,867
Restricted Funds:
Tackle Man Van
National Lottery Community
Fund
Tackliro Prostste Cancer- peer lo
peer support for man with prostale
cancer
Other restricted funds
2,500
2,500
61.747
28,985
67,946
12,450
(73,757)
{11,678)
55,936
29,757
Total Restricted Funds
93.232
80,396
(85,435)
88,192
Total Funds
198,609
120,251
123800
195,059
Pa￿.. 19